Filing Details

Accession Number:
0001181431-11-056914
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-18 14:39:58
Reporting Period:
2011-11-17
Filing Date:
2011-11-18
Accepted Time:
2011-11-18 14:39:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478832 Ken Bartizal C/O Trius Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego CA 92121
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-11-17 1,687 $7.85 109,844 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2011.
  2. Includes 4,654 and 7,168 shares of Common Stock that were acquired by the Reporting Person on 11/19/10 and 5/20/11, respectively, pursuant to the Issuer's Employee Stock Purchase Plan.